JBC: A shadowy organizational hub in cells
On a cellular level, we are all hanging on by delicate threads. All cells are crisscrossed by a network of strands called microtubules, which act as railroad tracks that move cargo around the cell, as winch cables that separate chromosomes during cell division and as scaffolding components that give a cell its shape.
Because of its essential role in the cell cycle, microtubule assembly is the target of essential anti-cancer chemotherapies (paclitaxel, for example), which stop out-of-control cell division by destabilizing microtubules. Now, researchers have shed light on the role that a large, enigmatic protein plays in assembling microtubules, paving the way for better treatments. The results of the research were published in the Journal of Biological Chemistry.
A large protein coordinates cellular components required for microtubule assembly.Courtesy of James Goldenring, Vanderbilt University
In 1999, James Goldenring’s research team at Vanderbilt University showed that protein kinase A-anchoring protein 350, or AKAP350, is a component of the centrosome, a center of microtubule organization in human cells. The team later showed that microtubules did not form efficiently without AKAP350. But the way in which AKAP350 regulated microtubule formation was difficult to understand, largely because of the technical challenges posed by AKAP350’s heft.
“Since this protein is so huge, it’s very difficult to study it,” said Elena Kolobova, the research scientist in Goldenring’s laboratory who led the new study. “A few years ago, we finally came to develop synthetic constructs of (AKAP350), which allowed us to go to the next level of evaluation and function.”
Using a combination of detailed biochemical analyses and super-resolution microscopy, the team finally was able to gain some understanding of the complex roles that AKAP350 plays in regulating microtubules in cells. AKAP350 formed a physical bridge spanning components of the centrosome. And AKAP350 appeared to recruit multiple proteins involved in building microtubules, coordinating their function in one spot.
“I like to call this thing Deep Space Nine. Everybody comes to hang out at AKAP350,” Goldenring said. “I think we’ve only scratched the surface of the structural organization that this protein is probably providing.”
Mutations in AKAP350 have been associated with cardiac arrhythmias, so it will be of interest to see whether the protein’s role in microtubule assembly contributes to proper heart function as well.
“I think (AKAP350) is a fundamental regulator of cell function,” Goldenring said. “So we need to know a lot more about this protein before we can even begin looking at what it might mean for disease.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.